Terms: = Breast cancer AND FOXL2, BPES, 668, ENSG00000183770, P58012, PFRK, POF3, PINTO, BPES1 AND Prognosis
29 results:
1. Construction and validation of a cuproptosis-related five-lncRNA signature for predicting prognosis, immune response and drug sensitivity in breast cancer.
Li C; Zhang Y
BMC Med Genomics; 2023 Jul; 16(1):158. PubMed ID: 37422644
[TBL] [Abstract] [Full Text] [Related]
2. The association of hypoxia-inducible factor-1α and hypoxia-inducible factor-2α protein expression with clinicopathological characteristics in papillary thyroid carcinoma: A meta-analysis.
Lin X; Su H; Huo J; Zhang F
Medicine (Baltimore); 2023 Jun; 102(24):e34045. PubMed ID: 37327294
[TBL] [Abstract] [Full Text] [Related]
3. Predicting the prognosis of HER2-positive breast cancer patients by fusing pathological whole slide images and clinical features using multiple instance learning.
Wang Y; Zhang L; Li Y; Wu F; Cao S; Ye F
Math Biosci Eng; 2023 Apr; 20(6):11196-11211. PubMed ID: 37322978
[TBL] [Abstract] [Full Text] [Related]
4. COL11A1 as an novel biomarker for breast cancer with machine learning and immunohistochemistry validation.
Shi W; Chen Z; Liu H; Miao C; Feng R; Wang G; Chen G; Chen Z; Fan P; Pang W; Li C
Front Immunol; 2022; 13():937125. PubMed ID: 36389832
[TBL] [Abstract] [Full Text] [Related]
5. Hsa-miR-1248 suppressed the proliferation, invasion and migration of colorectal cancer cells via inhibiting PSMD10.
Wang C; Wang B; Liang W; Zhou C; Lin W; Meng Z; Wu W; Wu M; Liao Y; Li X; Zhao J; He Y
BMC Cancer; 2022 Aug; 22(1):922. PubMed ID: 36028821
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic Impact of Radiation Therapy in Pure Mucinous breast Carcinoma.
Chevli N; Wang K; Haque W; Schwartz MR; Nangia J; Sasaki J; Farach AM; Hatch SS; Butler EB; Teh BS
Clin Breast Cancer; 2022 Oct; 22(7):e807-e817. PubMed ID: 35915020
[TBL] [Abstract] [Full Text] [Related]
7. Development and validation of a nomogram to predict survival for advanced male breast cancer.
Zhang LP; Lin H; Wang AJ
Andrologia; 2022 Sep; 54(8):e14479. PubMed ID: 35618959
[TBL] [Abstract] [Full Text] [Related]
8. The diagnostic and prognostic values of microRNA-196a in cancer.
Xiong M; Wang P; Pan B; Nie J; Wang S; He B
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33289788
[TBL] [Abstract] [Full Text] [Related]
9. [Epidemiological and anatomopathological profile of breast cancer at the Ibn Rochd University Hospital, Casablanca].
Fouhi ME; Benider A; Gaëtan KZA; Mesfioui A
Pan Afr Med J; 2020; 37():41. PubMed ID: 33209168
[TBL] [Abstract] [Full Text] [Related]
10. HER2 borderline is a negative prognostic factor for primary malignant breast cancer.
Bhattacharjee A; Rajendra J; Dikshit R; Dutt S
Breast Cancer Res Treat; 2020 May; 181(1):225-231. PubMed ID: 32236825
[TBL] [Abstract] [Full Text] [Related]
11. Construction and Validation of Nomograms for Predicting Overall Survival and cancer-Specific Survival in Nonmetastatic Inflammatory breast cancer Patients Receiving Tri-Modality Therapy: A Population-Based Study.
Huang Q; Xu TY; Wu ZY
Med Sci Monit; 2019 Dec; 25():9167-9178. PubMed ID: 31789307
[TBL] [Abstract] [Full Text] [Related]
12. Triple-negative breast cancer: Pretreatment magnetic resonance imaging features and clinicopathological factors associated with recurrence.
Lee YJ; Youn IK; Kim SH; Kang BJ; Park WC; Lee A
Magn Reson Imaging; 2020 Feb; 66():36-41. PubMed ID: 31785544
[TBL] [Abstract] [Full Text] [Related]
13. Tumor-Infiltrating Lymphocytes in a Contemporary Cohort of Women with Ductal Carcinoma In Situ (DCIS).
Darvishian F; Ozerdem U; Adams S; Chun J; Pirraglia E; Kaplowitz E; Guth A; Axelrod D; Shapiro R; Price A; Troxel A; Schnabel F; Roses D
Ann Surg Oncol; 2019 Oct; 26(10):3337-3343. PubMed ID: 31240590
[TBL] [Abstract] [Full Text] [Related]
14. Nomogram-Predicted Survival of breast cancer Brain Metastasis: a SEER-Based Population Study.
Xiong Y; Cao H; Zhang Y; Pan Z; Dong S; Wang G; Wang F; Li X
World Neurosurg; 2019 Aug; 128():e823-e834. PubMed ID: 31096027
[TBL] [Abstract] [Full Text] [Related]
15. Large-scale analysis of
Croes L; Beyens M; Fransen E; Ibrahim J; Vanden Berghe W; Suls A; Peeters M; Pauwels P; Van Camp G; Op de Beeck K
Clin Epigenetics; 2018; 10():51. PubMed ID: 29682089
[TBL] [Abstract] [Full Text] [Related]
16. External validation of Modified breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience.
Griguolo G; Jacot W; Kantelhardt E; Dieci MV; Bourgier C; Thomssen C; Bailleux C; Miglietta F; Braccini AL; Conte P; Ferrero JM; Guarneri V; Darlix A
Breast; 2018 Feb; 37():36-41. PubMed ID: 29073498
[TBL] [Abstract] [Full Text] [Related]
17. Glutaminase expression is a poor prognostic factor in node-positive triple-negative breast cancer patients with a high level of tumor-infiltrating lymphocytes.
Kim JY; Heo SH; Choi SK; Song IH; Park IA; Kim YA; Park HS; Park SY; Bang WS; Gong G; Lee HJ
Virchows Arch; 2017 Apr; 470(4):381-389. PubMed ID: 28185053
[TBL] [Abstract] [Full Text] [Related]
18. Critical evaluation of KCNJ3 gene product detection in human breast cancer: mRNA in situ hybridisation is superior to immunohistochemistry.
Kammerer S; Jahn SW; Winter E; Eidenhammer S; Rezania S; Regitnig P; Pichler M; Schreibmayer W; Bauernhofer T
J Clin Pathol; 2016 Dec; 69(12):1116-1121. PubMed ID: 27698251
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort.
Jansson S; Bendahl PO; Larsson AM; Aaltonen KE; Rydén L
BMC Cancer; 2016 Jul; 16():433. PubMed ID: 27390845
[TBL] [Abstract] [Full Text] [Related]
20. Pretreatment Insulin Levels as a Prognostic Factor for breast cancer Progression.
Ferroni P; Riondino S; Laudisi A; Portarena I; Formica V; Alessandroni J; D'Alessandro R; Orlandi A; Costarelli L; Cavaliere F; Guadagni F; Roselli M
Oncologist; 2016 Sep; 21(9):1041-9. PubMed ID: 27388232
[TBL] [Abstract] [Full Text] [Related]
[Next]
